Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Focal drug administration via heparin-containing cryogel microcarriers reduces cancer growth and metastasis

Newland, Ben ORCID: https://orcid.org/0000-0002-5214-2604, Varricchio, Carmine ORCID: https://orcid.org/0000-0002-1673-4768, Körner, Yvonne, Hoppe, Franziska, Taplan, Christian, Newland, Heike ORCID: https://orcid.org/0000-0002-5214-2604, Eigel, Dimitri, Tornillo, Giusy, Pette, Dagmar, Brancale, Andrea ORCID: https://orcid.org/0000-0002-9728-3419, Welzel, Petra B., Seib, F. Philipp and Werner, Carsten 2020. Focal drug administration via heparin-containing cryogel microcarriers reduces cancer growth and metastasis. Carbohydrate Polymers 245 , 116504. 10.1016/j.carbpol.2020.116504

[thumbnail of Focal+drug+administration+via+heparin-containing+cryogel+microcarriers+reduces+cancer+growth+and+metastasis.pdf] PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB)

Abstract

Developing drug delivery systems that release anticancer drugs in a controlled and sustained manner remains challenging. We hypothesized that highly sulfated heparin-based microcarriers would allow electrostatic drug binding and controlled release. In silico modelling showed that the anticancer drug doxorubicin has affinity for the heparin component of the microcarriers. Experimental results showed that the strong electrostatic interaction was reversible, allowing both doxorubicin loading and a subsequent slow release over 42 days without an initial burst release. The drug-loaded microcarriers were able to reduce cancer cell viability in vitro in both hormone-dependent and highly aggressive triple-negative human breast cancer cells. Focal drug treatment, of an in vivo orthotopic triple-negative breast cancer model significantly decreased tumor burden and reduced cancer metastasis, whereas systemic administration of an equivalent drug dose was ineffective. This study proves that heparin-based microcarriers can be used as drug delivery platforms, for focal delivery and sustained long-term drug release.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Pharmacy
Publisher: Elsevier
ISSN: 0144-8617
Date of First Compliant Deposit: 17 June 2020
Date of Acceptance: 21 May 2020
Last Modified: 11 Jan 2024 20:57
URI: https://orca.cardiff.ac.uk/id/eprint/132570

Citation Data

Cited 11 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics